Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Apr 13, 2012 · 10-K · 104 days after period end · 0001144204-12-021574
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$12.58M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Apr 13, 2012 · 104 d after period end
